Filing Flows › Lemaitre Vascular (LMAT) › Capital expenditures
Lemaitre Vascular (LMAT) capital expenditures by quarter
Lemaitre Vascular's capital expenditures were $2.3M in Q3 2026 (third quarter 2026), +0.9% from Q2 2026. Over the last 7 quarters it ranged from $1.3M (Q2 2025) to $2.8M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.3M | +0.9% | +2% |
| Q2 2026 | $2.3M | -17% | +72% |
| Q1 2026 | $2.8M | +57% | +101% |
| Q4 2025 | $1.8M | -22% | — |
| Q3 2025 | $2.3M | +70% | — |
| Q2 2025 | $1.3M | -3% | — |
| Q1 2025 | $1.4M | — | — |
Q3 2026 at a glance
Lemaitre Vascular, Q3 2026: revenue $68.0M (+11% year over year), operating margin 26.0%, net earnings $15.0M, operating cash flow $22.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lemaitre Vascular's capital expenditures?
Lemaitre Vascular's capital expenditures were $2.3M in Q3 2026 (third quarter 2026), +0.9% from Q2 2026.
How has Lemaitre Vascular's capital expenditures changed?
Over the last 7 quarters it ranged from $1.3M (Q2 2025) to $2.8M (Q1 2026).